Madam Therapeutics

Feature Article on Madam Therapeutics and LUMC partnership in the Health~Holland Update September 2017

In an interview in the September issues of the Health~Holland Update, Remko Van Leeuwen, CEO of Madam Therapeutics tells about how the PPP Allowance from the Dutch government has strengthened the collaboration with the LUMC during the fundamental stages of their collaborative research. While describing that it can be challenging for a company to be involved in the research at such an early time point, this PPP allowance mechanism provides the extra support for such collaboration. In fact, Van Leeuwen explains that he believes it can be very helpful for parties to initiate first contact between a company and a research organisation before jointly starting an R&D project.

The full interview can be viewed here

Leave a Reply

Your email address will not be published. Required fields are marked *